Startup Spotlight: Two Raleigh biopharma firms join forces in search for potential therapies

RESEARCH TRIANGLE PARK – Raleigh-based Aceragen, a biopharmaceutical company developing therapeutics for rare and orphan diseases, has acquired Arrevus, another Raleigh company with a similar focus.